Juergen Debus Selected Research

Antigens

1/2021	Diagnostic Accuracy of 18F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence.
1/2020	Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management.
12/2017	68Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters.
1/2017	Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.
1/2005	Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juergen Debus Research Topics

Disease

57	Neoplasms (Cancer) 11/2023 - 07/2003
17	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 07/2003
14	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2005
11	Carcinoma (Carcinomatosis) 01/2024 - 01/2005
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 09/2008
10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 04/2011
8	Breast Neoplasms (Breast Cancer) 05/2023 - 01/2002
8	Adenoid Cystic Carcinoma (Cylindroma) 01/2020 - 07/2005
6	Glioma (Gliomas) 01/2022 - 12/2003
6	Brain Neoplasms (Brain Tumor) 01/2020 - 09/2008
6	Sarcoma (Soft Tissue Sarcoma) 12/2018 - 11/2008
5	Esophageal Neoplasms (Esophageal Cancer) 01/2024 - 08/2014
5	Lung Neoplasms (Lung Cancer) 11/2023 - 03/2013
5	Endometrial Neoplasms (Endometrial Cancer) 07/2023 - 06/2014
5	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2005
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019 - 07/2007
5	Ovarian Neoplasms (Ovarian Cancer) 07/2015 - 12/2007
3	Adenocarcinoma 05/2022 - 07/2015
3	Meningioma (Meningiomas) 01/2021 - 01/2019
3	Pathologic Constriction (Stenosis) 10/2019 - 01/2006
3	Squamous Cell Carcinoma of Head and Neck 02/2019 - 06/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 07/2015
3	Fibrosis (Cirrhosis) 01/2019 - 11/2017
3	Anus Neoplasms (Anal Cancer) 03/2015 - 05/2014
3	Rectal Neoplasms (Rectal Cancer) 03/2015 - 09/2008
2	Lymphatic Metastasis 05/2023 - 03/2008
2	Pain (Aches) 11/2019 - 04/2014
2	Malignant Mesothelioma 09/2017 - 12/2015
2	Hyperglycemia 01/2016 - 12/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2013 - 01/2013
2	Nasopharyngeal Carcinoma 01/2013 - 03/2011
2	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2013 - 03/2011
2	Necrosis 05/2012 - 01/2005
2	Xerostomia 12/2011 - 03/2011
2	Ovarian Epithelial Carcinoma 01/2011 - 12/2007
1	Angiofibroma 10/2023
1	Gastritis 04/2022
1	Hemorrhage 04/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Ascites 01/2021
1	Peritoneal Neoplasms 01/2021
1	Dermatitis 01/2020
1	Adenocarcinoma of Lung 01/2020

Drug/Important Bio-Agent (IBA)

16	CarbonIBA 01/2022 - 03/2014
10	Protons (Proton)IBA 10/2023 - 03/2014
8	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2005
6	IonsIBA 01/2022 - 03/2014
5	AntigensIBA 01/2021 - 01/2005
4	Temozolomide (Temodar)FDA LinkGeneric 12/2017 - 09/2008
4	PlatinumIBA 06/2011 - 12/2007
3	68Ga-FAPIIBA 11/2023 - 01/2020
3	Cetuximab (Erbitux)FDA Link 05/2022 - 04/2014
3	LigandsIBA 05/2022 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2009
2	KinesinsIBA 01/2021 - 04/2019
2	gallium 68 PSMA-11IBA 01/2019 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2018
2	Metformin (Glucophage)FDA LinkGeneric 12/2017 - 12/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017 - 12/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 12/2015
2	Carboplatin (JM8)FDA LinkGeneric 07/2015 - 04/2010
2	taxaneIBA 07/2015 - 04/2010
2	Semaxinib (SU5416)IBA 12/2003 - 07/2003
2	Angiogenesis InhibitorsIBA 12/2003 - 07/2003
1	RadiopharmaceuticalsIBA 11/2023
1	AndrogensIBA 10/2023
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 05/2022
1	Gemcitabine FDA Link 05/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021
1	filanesibIBA 01/2021
1	ispinesibIBA 01/2021
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	FAPI-46IBA 01/2020
1	NivolumabIBA 11/2019
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2019

Therapy/Procedure

84	Radiotherapy 01/2024 - 07/2003
37	Therapeutics 10/2023 - 12/2003
28	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2024 - 01/2002
18	Drug Therapy (Chemotherapy) 04/2022 - 01/2005
10	Heavy Ion Radiotherapy 11/2023 - 10/2018
10	Adjuvant Radiotherapy 05/2023 - 01/2002
6	Combined Modality Therapy 01/2019 - 07/2005
5	Prostatectomy (Retropubic Prostatectomy) 10/2023 - 01/2014
5	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2014
5	Chemoradiotherapy 10/2020 - 09/2008
5	Re-Irradiation 03/2020 - 01/2005
5	Brachytherapy 11/2018 - 01/2005
5	Adjuvant Chemotherapy 05/2014 - 04/2010
4	Immunotherapy 11/2019 - 01/2005
4	Palliative Care (Palliative Therapy) 03/2015 - 06/2010
3	Proton Therapy 10/2023 - 01/2022
3	Conformal Radiotherapy 04/2019 - 08/2017
2	Segmental Mastectomy (Lumpectomy) 05/2023 - 03/2013
2	Drug Tapering 11/2019 - 10/2018
2	Neoadjuvant Therapy 01/2018 - 12/2015
2	Image-Guided Radiotherapy 06/2011 - 11/2009
1	Conservative Treatment 04/2022